2015 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

Study of Y-90 Radioembolization Using Glass Microspheres Presented

March 4, 2015 -- Findings from a study that aimed to evaluate survival and safety outcomes for patients with hepatic metastases of colorectal cancer treated with yttrium-90 (Y…

Vascutek to Distribute Vascular Flow Technologies’ Spiral Flow Grafts in Europe

March 4, 2015 -- Vascular Flow Technologies announced that Vascutek, Ltd., will be an exclusive regional distributor in France, Germany, Austria, and Switzerland. The company …

Jotec Launches E-tegra AAA Stent Graft System in Europe

March 3, 2015 -- Jotec GmbH announced the European launch of the E-tegra abdominal aortic aneurysm (AAA) stent graft system, which received CE Mark approval in November 2014. …

ArtVentive Introduces EOS Device in the United States

March 3, 2015 -- ArtVentive Medical Group, Inc. announced the introduction of the company’s EOS (endoluminal occlusion system) in the United States with the first proced…

BIOLUX P-I Study of Biotronik’s Passeo-18 Lux DCB Published

March 3, 2014 -- Biotronik announced that Dierk Scheinert, MD, et al published 12-month results from the BIOLUX P-I clinical study in the Journal of Endovascular The…

SIR Presents Study of 3D Printing as Innovative Method to Deliver Treatment

March 2, 2015 -- The Society of Interventional Radiology (SIR) announced findings from a study that suggest that three-dimensional (3D) printing could become a powerful tool i…

Cardinal Health to Acquire Cordis

March 2, 2015 -- Cardinal Health announced plans to acquire Johnson & Johnson’s Cordis business for $1.944 billion in cash. The transaction, which is expected to be …

Click here for more News coverage

Current Supplement

Sponsored by Medtronic PLC

The Latest in DCB Data

Translating Evidence to Practice

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Abbott Laboratories $47.35  0.72%
AstraZeneca PLC $68.18  0.58%
Boston Scientific Corporation $16.92  0.77%
BTG plc $746.00  0.81%
Cardiovascular Systems Inc. $37.35  1.41%
CR Bard Inc. $170.27  1.56%
Edwards Lifesciences Corp. $135.66  -0.07%
Endologix Inc. $15.93  -0.69%
Hansen Medical, Inc. $0.83  2.12%
Vascular Market Price  Change
Johnson and Johnson $102.43  0.77%
Lombard Medical, Inc. $5.38  -0.19%
Medtronic, Inc. $78.51  0.41%
Merit Medical Systems, Inc. $19.42  -0.69%
St. Jude Medical Inc. $67.57  0.64%
The Medicines Company $29.72  -0.80%
The Spectranetics Corporation $34.48  0.44%
TriVascular Technologies, Inc. $9.98  -1.77%
Vascular Solutions Inc. $29.13  -0.38%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.

Website Design by Sides Media